DLEU2 and myeloid leukemia: HOTTIP is upregulated in hepatocellular carcinoma, osteosarcoma, lung, prostate and other cancers [30]; DLEU2 is deleted in lymphocytic leukemia and epigenetically silenced in myeloid leukemia [31, 32].